Configurable Scientific
Multi-Agent Workflows
Orchestrate domain-specialized AI agents, computational tools, and expert review loops to execute complex pharmaceutical research workflows with precision.
Rather than relying on unconstrained, general-purpose chatbots, IB Genius deploys specialized agent teams trained on biomedical ontologies to streamline target discovery, literature synthesis, and clinical intelligence.
Specialized Multi-Agent Ecosystem
Configurable domain agents tailored to distinct pharmaceutical and clinical specializations.
IBCTGenius
Coordinates clinical study analytics, monitors endpoint outcomes, analyzes protocol criteria, and identifies relevant patient population characteristics across global registries.
IBCOGenius
Applies oncology-specific ontologies and mechanistic pathways to evaluate target viability, mechanism-of-action hypotheses, and combination therapy rationale.
IBBioGenius
Processes multi-omic sequences, transcriptomic datasets, and molecular binding annotations to correlate genetic variants with biological target behavior.
Controlled Execution & Enterprise Governance
Coordinated Multi-Agent Intelligence
Specialized domain agents operate both independently and in coordinated teams to synthesize cross-disciplinary evidence without conversational hallucinations.
Mandatory Human-in-the-Loop Review
Explicit verification checkpoints ensure scientific leads inspect intermediate assumptions, adjust parameters, and approve analytical outputs before execution.
Deterministic Workflow Governance
Every analytical run maintains a complete audit trail linking hypotheses, computational steps, model weights, and primary citations for reproducible results.
Modular Enterprise Integration
Easily interfaces with private corporate data lakes, custom in-house LLMs, proprietary laboratory assays, and computational chemistry tools.
Configure Your Research Team
Explore how IB Genius orchestrates agents alongside your scientific staff to accelerate repeatable research tasks with full traceability.
Request an Architecture Briefing